RSS-Feed abonnieren
DOI: 10.1055/s-0030-1255778
© Georg Thieme Verlag KG Stuttgart · New York
Endoscopic submucosal dissection for gastric lesions: results of an European inquiry
Publikationsverlauf
submitted 8 May 2010
accepted after revision 23 August 2010
Publikationsdatum:
30. September 2010 (online)
![](https://www.thieme-connect.de/media/endoscopy/201010/lookinside/thumbnails/10.1055-s-0030-1255778-1.jpg)
Background and study aims: In Japanese centers, endoscopic submucosal dissection (ESD) is commonly used for the resection of early gastric lesions. However, in Europe, only a few reports have been published. The aim of the current study was to survey the current use of ESD by European endoscopists.
Methods: Between April and May 2009, European endoscopists (n = 490) who had articles published in the journals Endoscopy and/or Gastrointestinal Endoscopy during 2007 and 2008 were asked to complete an online questionnaire.
Results: A total of 58 endoscopists completed the questionnaire (12 %). Only 20 centers performed ESD, which was mostly performed by a single endoscopist in each center. Each endoscopist had treated a mean of four cases during the previous year (mean total experience 11 ESDs) bringing a total of 510 ESDs across all European centers that responded (197 during the past year). Lesions were located in the antrum in 35 % of cases; 39 % were Paris classification IIa, 22 % IIa + b, and 18 % IIa + c. Overall, the average of mean lesion diameter was 15.7 mm (range 1 – 70.0 mm). Most cases were non-invasive high-grade intraepithelial neoplasia (44 %) or adenocarcinoma (36 %). An insulated-tipped knife (1 or 2) was used in 70 % of procedures and an average of the mean duration of procedures was 108 minutes. In all, 78 % of lesions were removed en bloc with an R0 rate of 77 %. Endoscopists experienced major complications (perforation or major bleeding) in 13 % of cases.
Conclusion: ESD in Europe seems to be performed at a few centers, with most endoscopists performing a low number of procedures, achieving a high rate of efficacy and a moderate rate of major complications. However, as a potential selection bias may have occurred, multicenter registries should be conducted to help address the problem of dissemination of this technique.
References
- 1 Black R J, Bray F, Ferlay J, Parkin D M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997; 33 1075-1107
- 2 Pinheiro P S, Tyczynski J E, Bray F. et al . Cancer incidence and mortality in Portugal. Eur J Cancer. 2003; 39 2507-2520
- 3 Ferlay J, Autier P, Boniol M. et al . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18 581-592
- 4 Gossner L. The role of endoscopic resection and ablation therapy for early lesions. Best Pract Res Clin Gastroenterol. 2006; 20 867-876
- 5 Gotoda T, Yamamoto H, Soetikno R M. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006; 41 929-942
- 6 Larghi A, Waxman I. State of the art on endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc Clin N Am. 2007; 17 441-469, v
- 7 Cao Y, Liao C, Tan A. et al . Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy. 2009; 41 751-757
- 8 Esaki M, Matsumoto T, Hirakawa K. et al . Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy. 2007; 39 41-45
- 9 Nakamoto S, Sakai Y, Kasanuki J. et al . Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy. 2009; 41 746-750
- 10 Watanabe K, Ogata S, Kawazoe S. et al . Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc. 2006; 63 776-782
- 11 Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007; 10 1-11
- 12 Deprez P, Aouattah T, Chun-Ping R. et al . Endoscopic resection of superficial gastric tumors [abstract]. Gastrointest Endosc. 2007; 65 AB164
- 13 Deprez P, Sempoux C, Jouret-Mourin A. et al . Endoscopic management of ESD and EMR perforations (abstract). Endoscopy. 2008; 40 A171
- 14 Pimentel-Nunes P, Dinis-Ribeiro M, Santos L. et al . Endoscopic submucosal dissection for gastric superficial lesions is also feasible in Europe (abstract). Endoscopy. 2009; 41 A214
- 15 Probst A, Arnholdt H, Anthuber M. et al . Endoscopic submucosal dissection (ESD) of large mucosal and submucosal lesions in the GI tract: experience in the Western world [abstract]. Gastrointest Endosc. 2007; 65 AB268
- 16 Probst A, Golger D, Pommer B. et al . Endoscopic submucosal dissection (ESD) of large mucosal and submucosal lesions in the GI tract – experience in the Western world (abstract). Endoscopy. 2009; 41 A542
- 17 Dinis-Ribeiro M, Pimentel-Nunes P, Afonso M. et al . A European case series of endoscopic submucosal dissection for gastric superficial lesions. Gastrointest Endosc. 2009; 69 350-355
- 18 Neuhaus H, Costamagna G, Deviere J. et al . Endoscopic submucosal dissection (ESD) of early neoplastic gastric lesions using a new double-channel endoscope (the ”R-scope”). Endoscopy. 2006; 38 1016-1023
- 19 Bergman J J. How to justify endoscopic submucosal dissection in the Western world. Endoscopy. 2009; 41 988-990
- 20 Choi I J, Kim C G, Chang H J. et al . The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc. 2005; 62 860-865
- 21 Kakushima N, Fujishiro M, Kodashima S. et al . A learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms. Endoscopy. 2006; 38 991-995
- 22 Yamamoto S, Uedo N, Ishihara R. et al . Endoscopic submucosal dissection for early gastric cancer performed by supervised residents: assessment of feasibility and learning curve. Endoscopy. 2009; 41 923-928
M. Dinis-RibeiroMD, PhD
Gastroenterology Department
Portuguese Oncology Institute of Porto
Rua Dr. Bernardino de Almeida
4200-072 Porto
Portugal
Fax: +351-22-5084055
eMail: mario@med.up.pt